WO2004084807A3 - Micro-cluster compositions - Google Patents

Micro-cluster compositions Download PDF

Info

Publication number
WO2004084807A3
WO2004084807A3 PCT/US2004/008039 US2004008039W WO2004084807A3 WO 2004084807 A3 WO2004084807 A3 WO 2004084807A3 US 2004008039 W US2004008039 W US 2004008039W WO 2004084807 A3 WO2004084807 A3 WO 2004084807A3
Authority
WO
WIPO (PCT)
Prior art keywords
micro
compositions
clustered
methods
clustered water
Prior art date
Application number
PCT/US2004/008039
Other languages
French (fr)
Other versions
WO2004084807A2 (en
Inventor
William D Holloway Jr
Michael A Holloway
Nikolai Tankovich
Eugene Baranov
Original Assignee
Aquaphotonics Inc
William D Holloway Jr
Michael A Holloway
Nikolai Tankovich
Eugene Baranov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/393,910 external-priority patent/US20040121022A1/en
Priority claimed from US10/420,280 external-priority patent/US20060198901A9/en
Priority claimed from US10/447,164 external-priority patent/US20060275378A9/en
Priority claimed from US10/680,771 external-priority patent/US20040126468A1/en
Priority to MXPA05010042A priority Critical patent/MXPA05010042A/en
Priority to AU2004224397A priority patent/AU2004224397A1/en
Application filed by Aquaphotonics Inc, William D Holloway Jr, Michael A Holloway, Nikolai Tankovich, Eugene Baranov filed Critical Aquaphotonics Inc
Priority to EP04757748A priority patent/EP1613352A4/en
Priority to BRPI0409023-3A priority patent/BRPI0409023A/en
Priority to CA002519488A priority patent/CA2519488A1/en
Priority to JP2006507242A priority patent/JP2006521811A/en
Priority to TW093124326A priority patent/TW200532021A/en
Publication of WO2004084807A2 publication Critical patent/WO2004084807A2/en
Publication of WO2004084807A3 publication Critical patent/WO2004084807A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Abstract

Micro-clustered liquids, methods of manufacture and use. Culture media and cultures comprising micro-clustered water; use of micro-clustered culture media and cultures for cell, tissue and organ maintenance and growth; use in microbial biotechnology. Micro-clustered water compositions of bio-affecting agents, body-treating agents, and adjuvants or carriers, pharmaceutical and diagnostic compositions thereof. Methods of using the compositions involving administering them ex vivo to cells, tissues or organs, or in vivo to living bodies; and methods of making the compositions. Methods of hydrating foods and food ingredients in food processing systems with micro-clustered water. Edible foods, ingredients, flavoring and sweetening compositions containing micro-clustered water.
PCT/US2004/008039 2003-03-20 2004-03-17 Micro-cluster compositions WO2004084807A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP2006507242A JP2006521811A (en) 2003-03-20 2004-03-17 Microcluster composition
CA002519488A CA2519488A1 (en) 2003-03-20 2004-03-17 Micro-cluster compositions
BRPI0409023-3A BRPI0409023A (en) 2003-03-20 2004-03-17 culture medium, method for preparing said medium, collection and cloning of stem cells, microaggregated water, composition and method for preparing it
EP04757748A EP1613352A4 (en) 2003-03-20 2004-03-17 Micro-cluster compositions
AU2004224397A AU2004224397A1 (en) 2003-03-20 2004-03-17 Micro-cluster compositions
MXPA05010042A MXPA05010042A (en) 2003-03-20 2004-03-17 Micro-cluster compositions.
TW093124326A TW200532021A (en) 2004-03-17 2004-08-13 Micro-cluster compositions of drugs, bio-affecting compositions, body-treating compositions, culture media, foods beverages

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US10/393,910 US20040121022A1 (en) 1999-10-26 2003-03-20 Culture media and methods of making and using culture media
US10/393,910 2003-03-20
US10/420,280 2003-04-21
US10/420,280 US20060198901A9 (en) 1999-10-26 2003-04-21 Drugs, bio-affecting and body treating compositions
US10/447,164 US20060275378A9 (en) 1999-10-26 2003-05-27 Culture media and methods of making and using culture media
US10/447,164 2003-05-27
US10/680,771 2003-10-07
US10/680,771 US20040126468A1 (en) 1999-10-26 2003-10-07 Food or edible material and beverages: processes, compositions, and products

Publications (2)

Publication Number Publication Date
WO2004084807A2 WO2004084807A2 (en) 2004-10-07
WO2004084807A3 true WO2004084807A3 (en) 2005-05-06

Family

ID=33102415

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/008039 WO2004084807A2 (en) 2003-03-20 2004-03-17 Micro-cluster compositions

Country Status (8)

Country Link
EP (1) EP1613352A4 (en)
JP (1) JP2006521811A (en)
KR (1) KR20060008299A (en)
AU (1) AU2004224397A1 (en)
BR (1) BRPI0409023A (en)
CA (1) CA2519488A1 (en)
MX (1) MXPA05010042A (en)
WO (1) WO2004084807A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9492404B2 (en) 2010-08-12 2016-11-15 Revalesio Corporation Compositions and methods for treatment of taupathy
US9523090B2 (en) 2007-10-25 2016-12-20 Revalesio Corporation Compositions and methods for treating inflammation

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2543250A1 (en) * 2007-02-17 2013-01-09 President and Fellows of Harvard College Compositions and method for tissue preservation
US10125359B2 (en) 2007-10-25 2018-11-13 Revalesio Corporation Compositions and methods for treating inflammation
US9745567B2 (en) 2008-04-28 2017-08-29 Revalesio Corporation Compositions and methods for treating multiple sclerosis
CN102088968A (en) 2008-02-15 2011-06-08 哈佛学院董事会 Blood substitute solution
WO2009148521A1 (en) * 2008-06-03 2009-12-10 Nestec S.A. Palatability enhancers and methods for enhancing palatability
BR112012027905A2 (en) * 2010-04-30 2015-09-08 Revalesio Corp methods and compositions to protect against neurotoxic agents
US20140302163A1 (en) * 2013-03-15 2014-10-09 Subtech Industries, LLC Water With Improved Transdermal and Cellular Delivery Properties and Methods Of Manufacture And Use Thereof
JP7087235B2 (en) * 2014-12-26 2022-06-21 メディサイエンス・エスポア株式会社 Oxygen solution and frozen ice
US20190029292A1 (en) 2016-01-15 2019-01-31 The Coca-Cola Company Continuous high pressure processing of food and beverage products
WO2017132229A1 (en) * 2016-01-29 2017-08-03 Lopez Noe Joshua Electrolytic treater and method for treating water

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5711950A (en) * 1990-01-12 1998-01-27 Lorenzen; Lee H. Process for preparing microclustered water

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05228476A (en) * 1991-12-13 1993-09-07 Koaazu Patent Raito Internatl:Kk Water containing micro water cluster and its manufacture
US6521248B1 (en) * 1999-10-26 2003-02-18 Bio-Hydration Research Lab, Inc. Micro-cluster liquids and methods of making and using them
JP3878968B2 (en) * 2001-07-17 2007-02-07 有限会社にらい農場 Elevated cultivation method and elevated cultivation bed

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5711950A (en) * 1990-01-12 1998-01-27 Lorenzen; Lee H. Process for preparing microclustered water

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1613352A4 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9523090B2 (en) 2007-10-25 2016-12-20 Revalesio Corporation Compositions and methods for treating inflammation
US9492404B2 (en) 2010-08-12 2016-11-15 Revalesio Corporation Compositions and methods for treatment of taupathy

Also Published As

Publication number Publication date
AU2004224397A1 (en) 2004-10-07
WO2004084807A2 (en) 2004-10-07
JP2006521811A (en) 2006-09-28
BRPI0409023A (en) 2006-03-28
MXPA05010042A (en) 2006-05-25
KR20060008299A (en) 2006-01-26
EP1613352A2 (en) 2006-01-11
CA2519488A1 (en) 2004-10-07
EP1613352A4 (en) 2009-04-29

Similar Documents

Publication Publication Date Title
CN102266274B (en) Agent for enhancing collagen production and uses thereof
CN107509906B (en) A kind of bitter buckwheat fruits and vegetables composite ferment powder and preparation method thereof
JP4026722B2 (en) Fermented plant extract, fermented plant powder and blended plant extract
CN106470548A (en) Antimicrobial compositions
WO2004084807A3 (en) Micro-cluster compositions
ES2892961B2 (en) Biomaterial formed by bacterial cellulose and probiotics and its uses
CN102191189B (en) Novel probiotic strain and application thereof
CN104023732A (en) Prophylactic or therapeutic agent for oral diseases
CN103686520A (en) Biological antibacterial microphone sleeve
JP2020068773A (en) Compositions containing products of lactic acid bacteria, methods for producing equol and methods for producing compositions containing products of lactic acid bacteria
CN104770731A (en) Cynomorium songaricum ferment and preparation technology thereof
CN103622125B (en) A kind of ginseng drink and preparation method thereof
CN102618452B (en) Preparation method, composition and application of lactobacillus salivarius and its metabolites
CN109832617A (en) A kind of orange peel fermented product and preparation method thereof
CN105231164A (en) Rose ferment and preparation method thereof
JP2006316053A (en) Cytotoxicity inhibitor and use thereof
KR100851290B1 (en) Method for producing fermented rice using living effective microorganisms and fermented rice produced by the same
Tester et al. A preliminary study of the synbiotic effects of konjac glucomannan hydrolysates (GMH) and lactobacilli on the growth of the oral bacterium Streptococcus mutans
SE0300002D0 (en) New product
CN110122868A (en) The smelly ginseng ferment of one kind, smelly ginseng ferment drink and preparation method
JP2006075083A (en) Fermented product obtained from balsam pear
CN107348274A (en) The method for preparing drinks using jellyfish collagen peptide fermentation
JP2021120371A (en) Anti-qi-counterflow agent
CN106165892A (en) A kind of production method of Xinhui citrus reticulata Flos Rosae Rugosae ferment
CN108464509A (en) Application of the novel fermentation Bacillus acidi lactici in field of food

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2519488

Country of ref document: CA

Ref document number: 2006507242

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2005/010042

Country of ref document: MX

Ref document number: 1020057017653

Country of ref document: KR

Ref document number: 4235/DELNP/2005

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2004224397

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 542661

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2004757748

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2004224397

Country of ref document: AU

Date of ref document: 20040317

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004224397

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 20048135215

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2004757748

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020057017653

Country of ref document: KR

ENP Entry into the national phase

Ref document number: PI0409023

Country of ref document: BR